文献速递头颈部肿瘤放疗放疗物理与技术

联合质子-光子放疗中质子治疗时段的最优分配

Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2021-04-20

本研究基于45例头颈部肿瘤患者(已有IMRT与IMPT计划)及荷兰质子筛选所用口干与吞咽困难NTCP模型,在质子时段有限的假设下,开发方法在群体层面最优分配联合质子-光子治疗中的质子分次以最小化平均NTCP,并与单模态质子或光子治疗的患者筛选策略比较。结果显示联合治疗因NTCP函数的非线性而优于患者筛选:初始质子分次获益最大,后续质子分次获益递减;该效应在本队列与所用NTCP模型下较小,若剂量-效应关系更明确可能更大。结论认为联合质子-光子治疗可更好利用有限的质子治疗资源,其相对患者筛选的获益取决于NTCP模型及质子与光子的剂量差异。

要点

  • 联合质子-光子治疗可在群体层面更充分利用有限的质子治疗时段。
  • NTCP函数非线性:初始质子分次获益最大,后续分次获益递减。
  • 获益大小取决于NTCP模型与质子-光子剂量差异。

核心结论

  • 联合质子-光子治疗可更好利用有限的质子治疗资源。
  • 联合治疗相对患者筛选策略的获益取决于NTCP模型及质子与光子的剂量差异。

研究设计与样本

  • 基于45例头颈部肿瘤患者,使用先前创建的IMRT与IMPT计划。
  • 结合荷兰用于质子患者筛选的口干与吞咽困难NTCP模型。
  • 在质子时段有限的假设下,开发方法最优分配联合治疗中的质子分次以最小化群体平均NTCP。
  • 将联合治疗与单模态质子或光子治疗的患者筛选策略进行比较。

主要发现

  • 联合质子-光子治疗相比患者筛选存在获益,归因于NTCP函数的非线性。
  • 初始质子分次获益最大,额外质子分次在NTCP曲线较平坦段获益递减。
  • 该效应在本患者队列与所考虑的NTCP模型下较小,若剂量-效应关系更明确可能更大。
  • 质子时段有限时,患者筛选方法面临时段闲置与为未来可能获益更大的患者保留时段之间的权衡。
  • 灵活的质子时段分配联合治疗可提供最优利用所有可用资源的方法。

临床怎么用

  • 在质子资源有限时,可考虑联合质子-光子治疗并按群体NTCP最优分配质子分次。
  • 分配质子分次时应考虑NTCP曲线的非线性,优先将质子分次用于获益最大的初始部分。

局限性

  • 联合治疗相对患者筛选的获益效应在本队列与所用NTCP模型下较小。
  • 获益大小取决于NTCP模型及质子与光子的剂量差异,剂量-效应关系尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Proton therapy is a limited resource that is not available to all patients who may benefit from it. We investigated combined proton-photon treatments, in which some fractions are delivered with protons and the remaining fractions with photons, as an approach to maximize the benefit of limited proton therapy resources at a population level. METHODS AND MATERIALS: To quantify differences in normal-tissue complication probability (NTCP) between protons and photons, we considered a cohort of 45 patients with head and neck cancer for whom intensity modulated radiation therapy and intensity modulated proton therapy plans were previously created, in combination with NTCP models for xerostomia and dysphagia considered in the Netherlands for proton patient selection. Assuming limited availability of proton slots, we developed methods to optimally assign proton fractions in combined proton-photon treatments to minimize the average NTCP on a population level. The combined treatments were compared with patient selection strategies in which patients are assigned to single-modality proton or photon treatments. RESULTS: There is a benefit of combined proton-photon treatments compared with patient selection, owing to the nonlinearity of NTCP functions; that is, the initial proton fractions are the most beneficial, whereas additional proton fractions have a decreasing benefit when a flatter part of the NTCP curve is reached. This effect was small for the patient cohort and NTCP models considered, but it may be larger if dose-response relationships are better known. In addition, when proton slots are limited, patient selection methods face a trade-off between leaving slots unused and blocking slots for future patients who may have a larger benefit. Combined proton-photon treatments with flexible proton slot assignment provide a method to make optimal use of all available resources. CONCLUSIONS: Combined proton-photon treatments allow for better use of limited proton therapy resources. The benefit over patient selection schemes depends on the NTCP models and the dose differences between protons and photons.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Loizeau N, Fabiano S, Papp D, et al. Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021. PMID: 33848609. doi:10.1016/j.ijrobp.2021.03.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。